🔗 Share this article

Chancellor Reeves has stated she is preparing "targeted action to tackle household expense pressures" in next month's financial statement.

In comments to the BBC, she emphasized that lowering inflation is a collective duty of both the government and the central bank.

The United Kingdom's inflation rate is forecast to be the highest among the G7 developed nations this calendar year and next.

Potential Utility Cost Interventions

Reports indicate the government could take action to lower energy bills, for example by cutting the current 5% rate of value-added tax charged on energy supplies.

An additional possibility is to cut some of the policy costs presently included in household expenses.

Budgetary Constraints and Analyst Predictions

The government will receive the next assessment from the official forecaster, the OBR, on the start of the week, which will show how much scope there is for these actions.

The consensus from the majority of analysts is that the Chancellor will have to declare tax increases or spending cuts in order to fulfill her self-imposed debt limits.

Previously on Thursday, calculations indicated there was a £22 billion gap for the chancellor to fill, which is at the more modest range of forecasts.

"It is a collective job between the central bank and the administration to continue tackling some of the causes of price increases," the Chancellor stated to reporters in Washington, at the conferences of the IMF and global financial institution.

Tax Pledges and Global Concerns

While much of the focus has been on likely tax increases, the Treasury chief said the latest information from the OBR had not changed her vow to campaign commitments not to raise tax levels on earnings tax, VAT or National Insurance.

She blamed an "unpredictable world" with rising geopolitical and trade tensions for the Budget tax moves, likely to be targeted on those "wealthiest."

International Trade Disputes

Addressing concerns about the United Kingdom's commercial links with China she said: "The UK's security interests invariably come first."

Recent announcement by Chinese authorities to strengthen trade restrictions on critical minerals and other materials that are essential for advanced tech production led American leader Donald Trump to threaten an further 100% tariff on goods from the Asian country, raising the possibility of an full-scale commercial conflict between the two global powers.

The American finance chief called the Chinese action "commercial pressure" and "a international production control attempt."

Inquired about considering the American proposal to join its battle with the Asian nation, the Chancellor said she was "very concerned" by Chinese actions and encouraged the Beijing authorities "to avoid restrictions and limit trade."

She said the move was "damaging for the international commerce and causes further challenges."

"It is my opinion there are fields where we should address China, but there are also valuable prospects to export to Chinese markets, including financial services and other areas of the economy. We've got to get that balance appropriate."

The chancellor also confirmed she was cooperating with international partners "regarding our own essential resources strategy, so that we are less reliant."

Health Service Medicine Pricing and Funding

The Chancellor also acknowledged that the price the NHS pays for medicines could increase as a consequence of current talks with the US government and its pharmaceutical firms, in exchange for reduced taxes and funding.

Some of the world's largest pharmaceutical manufacturers have said recently that they are either delaying or abandoning projects in the United Kingdom, with some blaming the low prices they are getting.

Recently, the government science advisor said the price the health service pays for drugs would need to increase to stop businesses and drug research funding departing from the UK.

Reeves told media: "We have seen as a result of the cost structure, that drug testing, innovative medicines have not been available in the UK in the extent that they are in other EU nations."

"The objective is to guarantee that patients getting care from the National Health Service are able to access the top critical medicines in the globe. And so we are examining all of that, and... seeking to obtain more investment into Britain."